Literature DB >> 12297000

Identification of the dITP- and XTP-hydrolyzing protein from Escherichia coli.

Ji Hyung Chung1, Hyun-Young Park, Jong Ho Lee, Yangsoo Jang.   

Abstract

A hypothetical 21.0 kDa protein (ORF O197) from Escherichia coli K-12 was cloned, purified, and characterized. The protein sequence of ORF O197 (termed EcO197) shares a 33.5% identity with that of a novel NTPase from Methanococcus jannaschii. The EcO197 protein was purified using Ni-NTA affinity chromatography, protease digestion, and gel filtration column. It hydrolyzed nucleoside triphosphates with an O6 atom-containing purine base to nucleoside monophosphate and pyrophosphate. The EcO197 protein had a strong preference for deoxyinosine triphosphate (dITP) and xanthosine triphosphate (XTP), while it had little activity in the standard nucleoside triphosphates (dATP, dCTP, dGTP, and dTTP). These aberrant nucleotides can be produced by oxidative deamination from purine nucleotides in cells; they are potentially mutagenic. The mutation protection mechanisms are caused by the incorporation into DNA of unwelcome nucleotides that are formed spontaneously. The EcO197 protein may function to eliminate specifically damaged purine nucleotide that contains the 6-keto group. This protein appears to be the first eubacterial dITP- and XTPhydrolyzing enzyme that has been identified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297000     DOI: 10.5483/bmbrep.2002.35.4.403

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  11 in total

1.  Processing of DNA lesions by archaeal DNA polymerases from Sulfolobus solfataricus.

Authors:  Petr Grúz; Masatomi Shimizu; Francesca M Pisani; Mariarita De Felice; Yusuke Kanke; Takehiko Nohmi
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

2.  Defects in purine nucleotide metabolism lead to substantial incorporation of xanthine and hypoxanthine into DNA and RNA.

Authors:  Bo Pang; Jose L McFaline; Nicholas E Burgis; Min Dong; Koli Taghizadeh; Matthew R Sullivan; C Eric Elmquist; Richard P Cunningham; Peter C Dedon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Chromosomal fragmentation is the major consequence of the rdgB defect in Escherichia coli.

Authors:  Lisa Lukas; Andrei Kuzminov
Journal:  Genetics       Date:  2005-12-01       Impact factor: 4.562

4.  Determinants of Base-Pair Substitution Patterns Revealed by Whole-Genome Sequencing of DNA Mismatch Repair Defective Escherichia coli.

Authors:  Patricia L Foster; Brittany A Niccum; Ellen Popodi; Jesse P Townes; Heewook Lee; Wazim MohammedIsmail; Haixu Tang
Journal:  Genetics       Date:  2018-06-15       Impact factor: 4.562

5.  Hypoxanthine incorporation is nonmutagenic in Escherichia coli.

Authors:  Brian Budke; Andrei Kuzminov
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

6.  Structure of the orthorhombic form of human inosine triphosphate pyrophosphatase.

Authors:  Jason Porta; Carol Kolar; Stanislav G Kozmin; Youri I Pavlov; Gloria E O Borgstahl
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-25

7.  Production of clastogenic DNA precursors by the nucleotide metabolism in Escherichia coli.

Authors:  Brian Budke; Andrei Kuzminov
Journal:  Mol Microbiol       Date:  2009-11-25       Impact factor: 3.501

8.  The mutT defect does not elevate chromosomal fragmentation in Escherichia coli because of the surprisingly low levels of MutM/MutY-recognized DNA modifications.

Authors:  Ella Rotman; Andrei Kuzminov
Journal:  J Bacteriol       Date:  2007-07-06       Impact factor: 3.490

9.  Genome-wide screening for genes whose deletions confer sensitivity to mutagenic purine base analogs in yeast.

Authors:  Elena I Stepchenkova; Stanislav G Kozmin; Vladimir V Alenin; Youri I Pavlov
Journal:  BMC Genet       Date:  2005-06-02       Impact factor: 2.797

Review 10.  A disease spectrum for ITPA variation: advances in biochemical and clinical research.

Authors:  Nicholas E Burgis
Journal:  J Biomed Sci       Date:  2016-10-22       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.